Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT
Quince Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 168K | n/a | n/a | n/a | 36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 35K | 32K | 84K | 86K | 44K | 40K | 304K | n/a | 1K | 17K | 42K | 40K | 84K | 38K | 84K | 87K | 87K | 86K |
Gross Profit | -35K | -32K | 84K | -86K | -44K | -40K | -268K | n/a | -1K | -17K | -42K | -40K | -84K | -38K | -84K | -87K | -87K | -86K |
Operating Income | -9.89M | -14.86M | -12.01M | -5.86M | -28.19M | -11.22M | -8.34M | -6.09M | -5.58M | -12.96M | -6.32M | -7.62M | -16.26M | -21.86M | -23.54M | -21.68M | -21.78M | -23.31M |
Interest Income | 311K | 406K | 536K | 683K | 823K | 887K | 1.01M | 959K | 805K | 700K | 536K | 315K | 145K | 72K | 105K | 128K | 160K | 227K |
Pretax Income | -15.98M | -14.98M | -12.45M | -5.48M | -27.69M | -11.12M | -8.84M | -5.35M | -4.89M | -12.5M | -5.53M | -7.92M | -16.85M | -21.64M | -23.4M | -21.71M | -21.75M | -23.09M |
Net Income | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M | -12.25M | -5.82M | -8.22M | -16.56M | -21.42M | -23.4M | -21.71M | -21.75M | -23.09M |
Selling & General & Admin | 3.31M | 4.79M | 4.28M | 3.63M | 4.7M | 2.63M | 4.61M | 4.66M | 4.23M | 3.83M | 3.55M | 4.34M | 9.06M | 9.11M | 8.33M | 7.64M | 7.06M | 6.49M |
Research & Development | 6.55M | 8.14M | 5.83M | 4.92M | 4.15M | 3.5M | 3.43M | 1.43M | 1.35M | 3.23M | 2.77M | 2.45M | 7.2M | 12.76M | 15.21M | 14.04M | 14.72M | 16.82M |
Other Expenses | n/a | 1.92M | 1.9M | -2.68M | 19.35M | n/a | 1.88M | n/a | n/a | n/a | n/a | n/a | n/a | 150K | 40K | -157K | -131K | n/a |
Operating Expenses | 9.86M | 14.86M | 12.01M | 5.86M | 28.19M | 6.13M | 9.92M | 6.09M | 5.58M | 7.06M | 6.32M | 6.79M | 16.26M | 21.86M | 23.54M | 21.68M | 21.78M | 23.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -2.34M | -304K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.89M | 14.86M | 12.01M | 5.86M | 28.19M | 11.22M | 9.92M | 6.09M | 5.58M | 7.06M | 6.32M | 6.79M | 16.26M | 21.86M | 23.54M | 21.68M | 21.78M | 23.31M |
Income Tax Expense | 67K | -47K | 7K | 13K | 36K | 31K | 51K | n/a | n/a | -248K | 284K | 301K | -284K | -222K | n/a | 29K | -29K | -227K |
Shares Outstanding (Basic) | 46.69M | 43.94M | 43.26M | 43.16M | 43.1M | 43.01M | 40.97M | 36.07M | 35.92M | 35.86M | 36.14M | 35.61M | 32.47M | 30.13M | 29.77M | 29.77M | 29.59M | 29.55M |
Shares Outstanding (Diluted) | 46.69M | 43.94M | 43.26M | 43.16M | 43.1M | 43.01M | 40.97M | 36.07M | 35.92M | 35.86M | 36.14M | 35.61M | 32.47M | 30.13M | 29.77M | 29.77M | 29.59M | 29.55M |
EPS (Basic) | -0.34 | -0.34 | -0.28 | -0.13 | -0.64 | -0.26 | -0.22 | -0.15 | -0.14 | -0.34 | -0.16 | -0.23 | -0.51 | -0.71 | -0.79 | -0.73 | -0.74 | -0.78 |
EPS (Diluted) | -0.34 | -0.34 | -0.28 | -0.13 | -0.64 | -0.26 | -0.22 | -0.15 | -0.14 | -0.34 | -0.16 | -0.23 | -0.51 | -0.71 | -0.79 | -0.73 | -0.74 | -0.78 |
EBITDA | -15.95M | -14.86M | -10.09M | -8.46M | -8.8M | -8.63M | -12.54M | -6.09M | -5.58M | -7.04M | -6.28M | -6.75M | -16.17M | -21.82M | -23.46M | -21.59M | -21.7M | -23.23M |
EBIT | -15.98M | -12.93M | -10.11M | -8.55M | -8.84M | -8.67M | -12.85M | -6.09M | -5.58M | -7.06M | -6.32M | -6.79M | -16.26M | -21.86M | -23.54M | -21.68M | -21.78M | -23.31M |
Depreciation & Amortization | 35K | 32K | 16K | 86K | 44K | 40K | 304K | n/a | 1K | 17K | 42K | 40K | 84K | 38K | 84K | 87K | 87K | 86K |